双歧杆菌联合胃肠安丸与针刺对儿童功能性胃肠病的疗效及对MOT、5-HT的影响

芦秦梅; 张金双; 魏金霜; 王立丽; 胡晓; 王丽

doi:10.3969/j.issn.1671-038X.2021.12.002

双歧杆菌联合胃肠安丸与针刺对儿童功能性胃肠病的疗效及对MOT、5-HT的影响

- 1. 唐山中心医院儿科(河北唐山, 063000);
- 2. 唐山中建二局职工医院中医科;
- 3. 唐山市弘慈医院儿科;
- 4. 华中科技大学同济医学院附属武汉市中心医院儿科
基金项目:
河北省中医药管理局2021年科研计划项目（No：2021431）

详细信息

通讯作者: 芦秦梅,E-mail:cjj11009@163.com

中图分类号: R573

收稿日期: 2021-08-10

Efficacy of bifidobacterium combined with Weichang'an Pill and acupuncture on children with functional gastrointestinal disease and its influence on MOT and 5-HT

- 1. Department of Paediatrics, Tangshan Central Hospital, Tangshan, 063000, China;
- 2. Department of TCM, Tangshan Zhongjian Second Bureau Staff Hospital;
- 3. Department of Paediatrics, Hirohito Hospital of Tangshan;
- 4. Department of Paediatrics, Wuhan Central Hospital, Affiliated to Tongji Medical College of Huazhong University of Science and Technology

More Information

Corresponding author: LU Qinmei, E-mail: cjj11009@163.com

Received Date: 10 August 2021

摘要

摘要: 目的：探究双歧杆菌联合胃肠安丸与针刺对儿童功能性胃肠病的疗效及对MOT、5-HT的影响。方法：选取2019年6月-2020年6月就诊的90例患者进行研究，按照住院的序列号前后，随机数表法对患者进行分组，研究组30例、对照组30例、双歧杆菌联合胃肠安丸组30例。研究组采用双歧杆菌联合胃肠安丸与针刺对患儿进行治疗。对照组采用双歧杆菌对患儿进行治疗。观察指标为临床主要症状、临床疗效、胃电图、血清相关胃肠激素。结果：对比3组在治疗前后的临床症状发生率，治疗前3组的临床症状差异无统计学意义（P>0.05），治疗后对照组恶心（5例）、呕吐（8例）、腹泻（8例）、腹痛（4例）例数均显著高于研究组（2例、4例、2例、1例），差异有统计学意义（P<0.05）。双歧杆菌联合胃肠安丸组腹痛（7例），腹泻（4例）要显著高于研究组（2例、1例）。研究组的临床治疗总有效率平均要优于对照组和双歧杆菌联合胃肠安丸组，差异有统计学意义（P<0.05），3组患者治疗后（餐前与餐后）胃动过缓以及胃电节律异常差异有统计学意义（P<0.05）。研究组治疗后胃电节律异常率和胃动过缓低于对照组和双歧杆菌联合胃肠安丸，差异有统计学意义（P<0.05）。对3组的血清进行比较，治疗前3组血清P物质（SP）、MOT、NO以及5-HT，差异无统计学意义（P>0.05），治疗后3组血清SP、MOT、NO以及5-HT水平都显著性升高，差异有统计学意义（P<0.05）。研究组指标平均高于对照组，双歧杆菌联合胃肠安丸组指标水平均高于对照组，差异有统计学意义（P<0.05）。结论：采用双歧杆菌联合胃肠安丸与针刺对儿童功能性胃肠病进行治疗，可以改善患者临床症状，提高临床疗效，值得在临床上进一步研究。
- 双歧杆菌 /
- 胃肠安丸 /
- 针刺 /
- 儿童 /
- 功能性胃肠病
Abstract: Objective: To explore the effects of bifidobacteria combined with Weichang'an pill and acupuncture on children with functional gastrointestinal disease and the influences on MOT and 5-HT. Methods: Ninety patients in our hospital from June 2019 to June 2020 were selected for study. According to the serial number before and after hospitalization, the patients were randomly divided into study group (30 cases), control group (30 cases) and Bifidobacterium plus Weichang'an Pill combination group (30 cases). The study group was treated with Bifidobacterium combined with Weichang'an Pill and acupuncture. The control group was treated with Bifidobacterium. The main clinical symptoms, clinical efficacy, electrogastrogram and serum related gastrointestinal hormones were observed. Results: Compared with the incidence of clinical symptoms before and after treatment, there was no significant difference among the three groups before treatment(P>0.05). After treatment, the cases of nausea(5 cases), vomiting(8 cases), diarrhea(8 cases) and abdominal pain(4 cases) in the control group were significantly higher than those in the study group(2 cases, 4 cases, 2 cases, 1 case), with a significant difference(P<0.05). Abdominal pain(7 cases) and diarrhea(4 cases) in Bifidobacterium combined with Weichang'an Pill group were significantly higher than those in the study group(2 cases, 1 case). The total effective rate of clinical treatment in the study group was better than that in the control group and Bifidobacterium combined with Weichang'an Pill group, with a significant difference(P<0.05). After treatment, there were significant differences in bradycardia and abnormal gastric electrical rhythm among the three groups(P<0.05). After treatment, the abnormal rate of gastric electric rhythm and bradycardia in the study group were lower than those in the control group and Bifidobacterium combined with Weichang'an Pill, with a significant difference(P<0.05). Comparing the serum of the three groups, there was no significant difference in substance P, MOT, NO and 5-HT among the three groups before treatment(P>0.05), but the levels of substance P, MOT, NO and 5-HT among the three groups increased significantly after treatment(P<0.05). The indexes of study group were higher than those of control group on average, and the indexes of Bifidobacterium combined with Weichang'an Pill group were higher than those of control group, with a significant difference(P<0.05). Conclusion: Bifidobacteria combined with Weichang'an Pills and acupuncture.can improve the clinical symptoms and the clinical efficacy in children with functional gastrointestinal disease. It is worthy of further clinical researches.
- bifidobacterium /
- Weichang'an Pill /
- acupuncture /
- children /
- functional gastrointestinal disease

HTML全文

参考文献(25)

[1]	杨婷, 江米足.儿童功能性便秘的诊治进展[J].中华儿科杂志, 2020, 58(7):611-614.
[2]	周丽、徐派的、张红星.肠道菌群与常见功能性胃肠病相关性的研究进展[J].华中科技大学学报(医学版), 2020, 49(6):108-112.
[3]	鲍文婷, 李在玲, 张华, 等.2~7岁儿童功能性便秘影响因素分析[J].中华实用儿科临床杂志, 2020, 35(12):917-921.
[4]	杨泽俊, 王田田, 尚宏伟, 等.肠道菌群代谢产物与脑-肠-骨髓轴在高血压调节中的作用[J].国际心血管病杂志2021, 48(1):17-21.
[5]	陈珊珊, 何阳, 张志华, 等.肠道菌群对抑郁症的影响及其可能机制的研究进展[J].医学研究生学报, 2020, 282(10):91-95.
[6]	杨秋蕊, 姜迪, 孟棵, 等.基于网络药理学探讨胃肠安丸治疗肠易激综合征的分子机制[J].中医杂志2021, 62(7):628-634, 644.
[7]	石芳, 郝旭曼, 刘阳, 等.胃肠安丸治疗功能性腹泻临床疗效评价[J].中医临床研究, 2018, 10(33):24-28.
[8]	高旭, 白晓晔, 郑慧娟, 等.双歧杆菌属特异性定量引物的设计及验证[J].微生物学报, 2020, 60(3):545-555.
[9]	Hoedt EC, Bongers RS, Bottacini F, et al.Bifidobacterium Transformation[J].Methods Mol Biol, 2021, 2278:13-19.
[10]	安婧, 刘诗.功能性胃肠病罗马Ⅳ诊断标准解读[J].医学新知杂志, 2017, 27(5):501-502.
[11]	Sahn B, Eze O P, Edelman M C, et al.Features of Intestinal Disease Associated with COVID-Related Multisystem Inflammatory Syndrome in Children[J].J Pediatric Gastroenterol Nutrit, 2020, (2), 89-91.
[12]	Bielefeldt K.Perceived Barriers to Treatment in Persons Treated for Functional Gastrointestinal Disease with Constipation[J].Dig Dis Sci, 2021, 35(12):917-921.
[13]	李晓陵, 刘世平, 曹丹娜, 等.基于脑fMRI技术针刺支沟穴特异性及脑网络的研究进展[J].磁共振成像, 2021, 12(5):110-113.
[14]	Arun PL, Ibrahim FS, Sara Z, et al.Bifidobacterium reduction is associated with high blood pressure in children with type 1 diabetes mellitus[J].Bio Pharmacot, 2021, 140(17):12-21.
[15]	Ga A, Dvs B, Mva C.The genus Bifidobacterium:from genomics to functionality of an important component of the mammalian gut microbiota[J].Comput Struct Biotechnol J, 2021, 19:1472-1487.
[16]	罗震宇, 金磊, 沈佳燕.参芪健胃颗粒联合复合凝乳酶胶囊对功能性消化不良儿童胃排空及胃肠激素水平的影响[J].中国中西医结合消化杂志, 2019, 27(5):347-350, 356.
[17]	张涛, 苏晓兰, 毛心勇, 等.胃肠安丸对葡聚糖硫酸钠诱导溃疡性结肠炎小鼠的治疗作用及机制[J].北京中医药, 2020, 39(3):205-210.
[18]	孔金凤.胃肠安丸联合莫沙必利片治疗儿童功能性消化不良的临床研究[J].中国现代药物应用, 2020, 14(24):191-121.
[19]	胡文辉, 陈玲玲, 金丽虹.布拉氏酵母菌联合乳果糖对儿童功能性便秘患儿血清肠神经递质指标的影响及疗效[J].中国中西医结合消化杂志, 2016, 24(9):706-708.
[20]	郅伟巍, 孙大庆.胃肠安丸联合三联疗法治疗伴有HP阳性的儿童功能性消化不良疗效及对胃肠动力的影响[J].陕西中医, 2017, 38(12):1683-1685.
[21]	李娟.三联双歧杆菌活菌散联合消旋卡多曲颗粒治疗儿童腹泻的安全性与有效性分析[J].中国社区医师, 2021, 37(11):27-28.
[22]	赵建红.胃肠安丸联合美沙拉嗪对溃疡性结肠炎患者血清炎症指标水平的影响[J].承德医学院学报.2020, 37(6):487-490.
[23]	杨丽萍, 马静岩, 贾丽霞.胃肠安丸联合双歧杆菌三联活菌胶囊治疗儿童抗生素相关性腹泻疗效观察[J].现代中西医结合杂志, 2016, 25(26):2858-2860.
[24]	陈元元.胃肠安丸联合双歧杆菌三联活菌胶囊治疗溃疡性结肠炎的疗效分析[J].现代诊断与治疗, 2021, 32(12):1867-1869.
[25]	钟慧, 杨蓉.益生菌与儿童功能性胃肠病的研究进展[J].淮海医药.2021, 39(2):213-216.